Publications & Abstracts
EndoBarrier as a Pre Bariatric Surgical Intervention in High-Risk Patients: a Feasibility Study
Endoscopically placed duodenal-jejunal bypass sleeve (EndoBarrier) has been designed to achieve weight loss and improve glycaemic control in...
Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes
A total of 1,064 studies were identified, 147 of which were duplicates. After abstract review, 741 studies were excluded, leaving 176 articles for...
Efforts to Resurrect EndoBarrier for Use in Obese With Diabetes
Medscape article by author Marlene Busko.
A Randomised Controlled Trial of a Duodenal-Jejunal Bypass Sleeve Device (EndoBarrier) Compared with Standard Medical Therapy for the Management of Obese Subjects with Type 2 Diabetes Mellitus
Endoscopically placed duodenal-jejunal bypass sleeve devices, such as the EndoBarrier (GI Dynamics, Lexington, Massachusetts, USA), have been...
Weight Reduction and Improvement in Diabetes by the Duodenal-Jejunal Bypass Liner: a 198 Patient Cohort Study
Treatment with the DJBL in T2DM patients with (morbid) obesity results in improvement in glucose control, a reduction in anti-diabetic medication,...
Endoscopic Bariatric and Metabolic Therapy: Surgical Analogues and Mechanisms of Action
This paper reviews major endoscopic bariatric therapies, their surgical analogues and proposed mechanisms of action. Clinical trial data for each...
EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism
The purpose of this study was to evaluate the efficacy and safety of Endobarrier® in grade 1 obese T2DM patients with poor metabolic control and the...
Measurement of Hepatic Insulin Sensitivity Early After the Bypass of the Proximal Small Bowel in Humans
The bypass of the proximal small bowel may have weight loss and even caloric restriction-independent glucose-lowering properties on hepatic insulin...
The Impact of EndoBarrier Gastrointestinal Liner in Obese Patients with Normal Glucose Tolerance and in Patients with Type 2 Diabetes
The duodenal-jejunal bypass sleeve ((DJBS) or EndoBarrier Gastrointestinal Liner) induces weight loss in obese subjects and may improve glucose...
EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography.
Many obese people with type 2 diabetes develop non-alcoholic fatty liver disease, which may progress to liver fibrosis. EndoBarrier gastrointestinal...
Videos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
